SPRB - Spruce Biosciences Inc. Profit before interest, taxes and amortization
The implementation of software robots for analyzing adrenal hyperplasia data influences the dynamics transmitted via the EBITDA aggregate on the GURU.Markets platform, and this metric equals 0.00. Profit growth is bolstered by strategic alliances to promote tildacerfont, while stable demand for lifelong hormone therapy for rare endocrine pathologies provides Spruce Biosciences (SPRB) with an endless cycle of proprietary product realization.
Summary analytical data breakdowns for Spruce Biosciences (SPRB)
- current quotes and average value forecast:
- market capitalization statistics:
- book capitalization data:
- company total debt and liquidity indicators:
Debt to Equity Spruce Biosciences|SPRB - Long-Term Debt to Equity|Current Liabilities to Capital sprucebiosciences.com|SPRB - Company Debts|Debt to Book Capitalization Ratio Spruce Biosciences|SPRB - Company Long-Term Debts|Short-Term Debt Volume Spruce Biosciences|Interim Coverage Ratio sprucebiosciences.com
- financial results and valuation multiples details:
SPRB - Company Net Income|Future Profit Spruce Biosciences|SPRB - Price to Earnings Ratio|Market Cap to Projected Earnings Spruce Biosciences Inc.|SPRB - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Spruce Biosciences|SPRB - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Spruce Biosciences|SPRB - Net earnings per share for the last 12 months|Quarterly EPS earnings growth sprucebiosciences.com|SPRB - Earnings growth in current year|Expected earnings per share growth for next year Spruce Biosciences
Analysis of all company metrics:Spruce Biosciences Inc. (SPRB)
Spruce Biosciences' development of drugs for rare endocrine pathologies requires colossal clinical trial expenditures, making cash flow control critical. By analyzing EBITDA, an investor can see the actual daily volume of operating cash excluding depreciation and amortization, which allows for an assessment of resource management efficiency and the company's ability to sustain research activities through operating revenue.
Who Spruce Biosciences competes with
ASND - Operating profit before deduction of amortization|Madrigal Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization corcept.com|RYTM (Rhythm Pharmaceuticals, Inc.) - Operating profit before deduction of amortization|AKRO: Company profit before taxes, interest and amortization|MTSR (Metsera Corp) - Operating profit EBITDA|Operating profit EBITDA MoonLake Corp|Operating profit EBITDA CRNX|Profit before payment of interest, taxes and amortization NAMS (newamsterdampharma.com)|Profit before payment of interest, taxes and amortization Soleno Therapeutics, Inc. SLNO|Amicus Therapeutics Inc (FOLD) - Profit before interest, taxes and amortization|ETNB - Profit before payment of interest, taxes and amortization|AGIO: Profit before payment of interest, taxes and amortization|GPCR: Operating profit EBITDA|MDXG - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Rezolute|Lexicon Pharmaceuticals Inc (LXRX) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization MBX Bio (MBX)|Operating profit before deduction of amortization Altimmune Pharma ALT|Profit before payment of interest, taxes and amortization Aardvark Therapeutics Inc AARD|Operating income before deduction of amortization sagimet.com (SGMT)|BIOA - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization BMEA|quincetx.com (QNCX) - Profit before payment of interest, taxes and amortization|Fractyl Health, Inc - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization VTVT|Operating profit EBITDA Agape ATP Corp.|Operating profit EBITDA PLUR|Operating profit before deduction of amortization synlogictx.com SYBX|Operating profit EBITDA LPCN (Lipocine Corp)|Matinas BioPharma Holdings, Inc. (MTNB) - Profit before interest, taxes and amortization|GLTO: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization CTCX (carmellrx.com)|LUMO: Operating profit EBITDA|ONVO (Organovo Holdings) - Profit before payment of interest, taxes and amortization|RDUS (Radius Health) - Operating profit EBITDA
